PAMELA LINZ: Open Payments
NPI 1114038718 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 5 payments from 4 companies in 2025. Trend: 2023 $678 · 2024 $758 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| BridgeBio Pharma, Inc. | 1 | $110 |
| Ethicon Inc. | 1 | $99 |
| Boston Scientific Corporation | 2 | $87 |
Products named: AMVUTTRA, Attruby, Monarch Platform, WATCHMAN FLX.
Industry payments across IN — which companies pay providers there.
